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INTRODUCTION  
Chronic kidney disease (CKD) prevalence is three to five times higher in the Bangladeshi 
population compared to other ethnic groups in the UK.1 Hypertension is both cause and 
consequence of CKD2 and extracellular volume expansion is an important factor in the 
development and maintenance of hypertension in CKD patients.3The British Bangladeshi 
population has an unusually high salt intake, twice that of the general population, which might 
contribute to both CKD and hypertension.4Patients with resistant hypertension, defined as BP 
that remains above target despite the use of three or more antihypertensive medications5, are 
thought to be salt sensitive.6 
Meta-analyses of salt restriction studies show a greater blood pressure (BP) lowering effect of 
salt restriction in hypertensive compared with normotensive subjects; under optimal conditions 
reductions in systolic/diastolic BP of 7/4 mm Hg7 can be obtained with  salt intake reduced to 
100 mmol/day. However, adherence to dietary advice is often poor resulting in smaller changes 
(<1mm Hg) in blood pressure of dubious clinical value. In previous work we investigated 
barriers to dietary salt restriction in Bangladeshi CKD patients in East London8 and developed a 
strategy intended to reduce salt intake in these patients. This present study set out to test the 
hypothesis that a low-salt educational intervention tailored to meet the needs, customs and 
practices of this population in addition to standard hypertension medication management would 
result in greater blood pressure reduction than standard care alone: a first such intervention with 
this population group.  
 
 
METHODS 
A parallel-group randomised trial design was selected, and conducted between June 2008 and 
July 2009. Ethical approval was obtained from the relevant Research Ethics Committee.  
Participants were patients with established moderate-severe CKD of Bangladeshi origin residing 
in East London, UK. Inclusion criteria were estimated glomerular filtration rate (eGFR) 
<60ml/min and mean BP >130/80mmHg on at least two clinic visits or taking antihypertensive 
medication. Patients on dialysis, those with a body mass index (BMI) <20 or >35 kg/m2, urinary 
incontinence, or cognitive impairment or mental problems impairing their ability to participate 
were excluded.  
Participants were recruited at the pre-dialysis clinic of a tertiary renal unit in London by the 
researcher. Participants were randomly assigned to the salt reduction intervention or usual care 
by the study statistician. Randomisation was by computer-generated random blocks with block 
sizes between four and eight to minimise selection bias. This was carried out by the statistician 
and the final list with group assignment given to the researcher. This was a dietary behaviour 
intervention, thus, neither participants nor the dietitian administering the intervention could be 
blinded to treatment allocation. Data analysis was conducted by the research statistician that was 
blinded to treatment allocation. 
  
Intervention 
The intervention group were initially advised by the study dietitian at the hospital. This was 
followed by practical cooking and educational sessions in the community facilitated by Bengali 
workers and attended by the researcher (see supplementary file). Community cooking sessions 
were delivered in conjunction with Community Kitchen UK (CKUK).9 In the community 
sessions, intervention participants cooked two versions of their traditional meals: one followed 
their usual recipe, the other had salt reduced by 50%. Fortnightly telephone calls from a Bengali 
worker followed, to reinforce advice and set new targets. The control group received usual care 
from the renal clinic in the form of a low sodium general dietary advice sheet sent by post with 
the physician’s letter. This had not been specifically adapted for Bangladeshi diets.  
 
Data collection 
Data collected at enrolment included age, sex, medication use and co-morbidities, including 
diabetes mellitus. Data collection for the primary outcome was by ambulatory blood pressure 
measured using TM-2430-13 devices (A&D Medical, Milpitas, CA; graded A/A by the British 
Hypertension Society) and Doctor Pro software, in accordance with recommendations10 day time 
measurements were taken at 30 min intervals, night time measurements every 60 min. Height, 
weight and body composition (total body water) were measured using the Fresenius Medical 
Care D GmbH Body Composition Monitor; blood samples were obtained for glycosylated 
haemoglobin (HbA1c). Physical activity levels were recorded using the YamaxDigi-Walker SW-
200 (Yamax Corporation, Tokyo, Japan) pedometer, shown to have an overall mean absolute 
error of 3% for outdoor normal walking.11 The accuracy of the pedometer on each participant 
was checked by a 20 step test at the outset, with an acceptance criterion of +/-2 steps.11Data were 
collected at two time points, at baseline and at end of study – six months later. 
 
Outcomes 
The primary outcome was reduction in systolic blood pressure (SBP) determined by 24hr 
ambulatory monitoring.  
Secondary outcomes were changes in diastolic blood pressure and reduction in estimated 
glomerular filtration rate (e-GFR).  
Measures of 24hr urinary sodium, potassium and creatinine were undertaken using routine 
methods at baseline and follow-up as indices of adherence to the intervention and determined by 
assessors blinded to treatment allocation. 
 
Statistical analysis 
Sample size calculation showed that a sample of 25 participants per group would convey 80% 
power to detect a significant reduction in the mean systolic BP of 8 mmHg at P<0.05 between 
the two groups (a clinically relevant difference), assuming a standard deviation of 10 mmHg.12 
Sample size was increased to 26 per group to allow for non-compliance or dropout. Analyses 
were conducted on an intention to treat basis. We took a P value of 0.05 to be significant. 
  
Changes within groups between baseline and follow-up at 6 months were compared using 
analysis of covariance and expressed as mean values with 95% confidence intervals. All reported 
P values were two sided. We used Stata 10 (StataCorp LP, Texas, USA) for data analysis.  
 
 
RESULTS 
Participant recruitment and progress through the trial is shown in Figure 1. Of the 56 participants 
recruited 6 withdrew; 3 cited the inconvenience of 24hr urine collection, 2 were unwilling to 
undergo ambulatory blood pressure monitoring and one was unwilling to attend the community 
cooking activity. One intervention group participant died; one control group member relocated to 
Bangladesh. Data were available for 48 participants. Details are shown in Table 1; groups were 
well matched including for antihypertensive medication, with most receiving angiotensin 
converting enzyme inhibitor or angiotensin-receptor blocking medicines and diuretics.  
 
Adherence to the dietary intervention 
All participants attended the initial briefing session with the study dietitian. Male participants 
attended with their wives, daughters or sisters whilst female participants attended with their 
daughters or daughters-in-law. Participants were split into four groups of six or seven to attend 
the community cooking sessions; each group were to attend two weekly consecutive sessions. 
Male participants chose not to attend but sent a female representative; a wife, daughter or sister 
for single men. The first weekly session was attended by 88% (23/25) of the participants or 
representatives; the second and final session was attended by 84% (21/25). Overall, all 
participants attended at least one cooking session.  
Adherence to dietary salt recommendations was indicated by urinary sodium excretion. At 
baseline urinary sodium excretion was approximately 260 mmol/24hr in both groups (Figure 2). 
Six months later, this had reduced by 122 mmol/24hr (95% CI -140.4,-104.9; P<0.001) in the 
intervention group, and by 13 mmol/24hrs (95% CI -17.7, -8.2; P<0.001) in the control group. At 
follow-up sodium excretion differed significantly between groups, by 103 mmol (95% CI -131,-
76; P<0.001). 
 
Primary and secondary outcomes:  
Systolic BP was elevated in both groups at baseline. Comparing changes from baseline to follow 
up in  mean 24hr SBP in both groups, reductions in intervention group values were significantly 
greater, at 8 (95% CI 5,11; P=0.0003) mm Hg lower. The intervention group showed significant 
(P<0.001) falls in day time and night systolic and diastolic BP compared to the same variables in 
the control group (Figure 3). Non-dipping, that is loss of the normal nocturnal reduction in night-
time systolic blood pressure, with a difference >10 mmHg between night and day time SBP, was 
observed in 60% (15/25) of the intervention group, 56% (13/23) of the control group at baseline. 
At follow up this reduced by 40% (6/25; P= 0.02) in the intervention group but remained 
unchanged in the control group.  
  
There were no differences between groups in changes in eGFR between baseline and follow-up. 
Kidney function declined by 3.0 (95% C 0.1,6.0) in the intervention compared to 3.4 (95% CI 
1.0,5.7) ml/min.1.73m2 in the control groups.  
 
 
Table 1. Baseline characteristics for the Intervention and Control groups   
 
 Control  
(n=23) 
Intervention 
(n=25) 
 
 Mean SD Mean SD 
 
Age (years) 
 
60.7 
 
12.0 
 
55.7 
 
15.1 
 
Male:female (numbers) 
 
14:9 
  
14:11 
 
 
Mean 24 hr systolic BP mmHg 
 
156.0 
 
10.7 
 
149.3 
 
15.2 
 
Mean 24 hr diastolic BP mmHg 
 
85 
 
5.8 
 
85 
 
6.3 
 
Diabetes (%) 
 
14 
 
(60) 
 
17 
 
68 
 
Glycosylated Hb (%) 
 
8.6 
 
1.8 
 
8.9 
 
1.9 
 
GFR ml/min/1.73m2 
 
42 
 
15.3 
 
41 
 
17.2 
 
Urinary sodium mmol/24hr 
 
Urinary Potassium mmol/24hr 
 
259 
 
39 
 
47.1 
 
6.9 
 
263 
 
43 
 
54.0 
 
4.0 
 
Urinary creatinine mmol/24hr 
 
11.15 
 
1.9 
 
10.75 
 
1.3 
 
Number BP medication/patient1 
 
3 
 
(2,4) 
 
3 
 
(2,4) 
 
Total body water (kg) 
 
33.1 
 
5.9 
 
33.4 
 
5.2 
 
BMI (kg/cm2) 
 
27.1 
 
5.2 
 
26.6 
 
5.4 
 
Physical activity (steps/day)1 
 
2,534 
 
1,101 
 
2,471 
 
1,419 
 
1Median with interquartile range                                                                                                                                                                                                 
 GFR - Glomerular filtration rate, BMI-body mass index. No statistical significant differences between the 
two groups       
  
Covariate findings 
Potassium excretion was low (40 mmol/d) in both groups and unchanged at follow-up. Physical 
activity levels were low in both groups and remained unchanged during the study. Glycosylated 
haemoglobin concentrations remained elevated at >8.0%, indicating poor but unchanging 
diabetic control in both groups. Body weight did not change in either group, but there was a 
modest but statistically significant reduction in mean total body water in the intervention group 
(0.50L, P<0.01) compared to no change in the control group (0.26L, n.s.). 
 
 
DISCUSSION  
Dietary advice to lower salt intake is routinely given to patients with CKD in the form of an 
information sheet; this study suggests this is ineffective at changing behaviour. By contrast, the 
dietitian-led intervention which identified the sources of salt in the Bangladeshi diet and 
developed strategies to lower intake, achieved a  reduction in dietary salt intake of over 100 
mmol/d. Whilst mean urinary sodium excretion still remained well above the UK target of 100 
mmol/day,13 post-intervention group results were more similar to those seen in the UK white 
population. This reduction in salt intake led to a highly significant fall in blood pressure of 8/3 
mmHg; very close to the figure predicted by meta-analyses.7  
The dietary approach used has also been shown to be effective in blood pressure reduction with 
other ethnic groups with high dietary salt intakes.14 Behavioural intervention studies have 
previously demonstrated that knowledge is a key contributing factor to adherence to low-salt 
diet12 and that lack of knowledge is a key barrier in dietary modification and adherence.15, 16 
However, knowledge of the need to reduce dietary salt intake is not always enough to ensure 
dietary modification and adherence. This study shows that knowledge tailored to recipients’ 
needs and contexts, delivered in a practical and acceptable manner, can effect behavioural 
change and achieve health benefits.  
Our previous studies showed that Bangladeshi CKD patients have much higher intakes of salt 
than the general population, with much of the salt being added during home preparation of food 
rather than during processing, as is the case in the general population. Consequently, routine 
advice for salt reduction designed for predominantly white European populations was not 
appropriate for this group of patients, for whom the engagement of family members was crucial. 
This was particularly relevant for these study participants, who almost exclusively ate home-
prepared meals in family groups.  
We noted that over half of the Bangladeshi CKD patients had raised BP throughout the day and 
night: the ‘non-dipping’ effect. Previously ‘non-dipping’ prevalence has been found to increase 
with worsening CKD, with 15% of normal subjects affected increasing to 75% in those with 
stage 5 CKD.17 Non-dipping has been associated with increased target-organ damage (heart, 
brain, kidney18-20), raised frequency of stroke and myocardial infarction,21 and higher 
cardiovascular mortality.20 Decreased salt intake and urinary sodium excretion led to greater 
reduction in night time SBP compared to daytime, and the restoration of the normal 
physiological night-time dip in blood pressure in many patients. In black salt-sensitive 
hypertensive patients salt restriction improved the circadian rhythm of blood pressure with a 
return to dipping pattern.22 Our study confirmed that salt reduction can change the pattern from 
‘non-dipper’ to ‘dipper’, and a recent review has concluded that the South Asian population are 
  
salt sensitive.23 A return to a ‘dipping’ BP pattern may lead to a significant reduction in the risk 
of vascular events for this patient group but long-term follow up is required to demonstrate this.  
  
Comparison with other studies 
 
Data supporting our findings were reported  by MacGregor et al,24 who demonstrated that when 
urinary sodium excretion dropped by 100mmol/24hr, subjects supine BP declined by 8/5 mm Hg 
(P<0.01); a sodium reduction of 150mmol/24hr led to a larger decline of 16/9mm Hg. Similarly, 
a modest salt reduction of 50 mmol/24hr (from a much lower baseline than in our participants: an 
average of 177 mmol/24hr) resulted in 7/3 mm Hg drop in blood pressure in a randomised trial in 
older people.25 A recent meta-analysis of 17 trials in hypertensive individuals over ≥4 weeks 
supports the approximate magnitude of this effect.7 A recent study of modest dietary sodium 
restriction in patients receiving angiotensin converting enzyme medicines showed an 11mm Hg 
reduction in SBP in non-diabetic nephropathy.26 Our study confirms this magnitude of 
association between reduction in sodium excretion and blood pressure values. 
 
Strengths and limitations 
The strength of this study is that it delivered an effective salt reduction dietary intervention for 
this group of patients, and demonstrated participants’ adherence to dietary advice through 24hr 
urinary sodium excretion. However, only single 24hr urine collections and 24hr ambulatory 
blood pressure recordings were made. Further, treatment allocation could not be blinded. It 
remains uncertain whether reducing blood pressure may translate into slowing of disease 
progression or reduction in cardiovascular events.  
 
 
Applicability and generalizability 
 
The Bangladeshi population and indeed the South Asian group are known for a high dietary salt 
intake, are at a high risk of CKD and thus, hypertension development. Dietary salt reduction can 
safely and usefully be extended to other family members who may in time also be at risk of 
developing hypertension. Other ethnic groups with a high prevalence of CKD and hypertension, 
such as Black African and Afro-Caribbean populations, may also benefit from tailored dietary 
interventions to reduce salt intake.  
 
 
CONCLUSION 
This study demonstrates the importance of tailoring dietary advice to patients’ contexts, cultures 
and needs, particularly for minority and high-risk groups. Healthcare professionals need 
education and training in methods to enable them to translate generic principles of healthy living 
and health promotion in such a way as to successfully deliver education and promote its 
application in the daily lives of their patients. Policy-makers need to recognise the importance of 
resourcing complementary approaches to medication for effective blood pressure control. An 
  
integrated approach, drawing on multiple successful approaches to hypertension reduction, offers 
the best option for blood pressure management in CKD patients.  
  
  
Legends 
Figure 1: CONSORT flowchart of participant recruitment, allocation and assessment 
 
Figure 2. 24hr urine sodium excretion for intervention and control groups at baseline and 
end study  
 
Figure 3. Changes in mean blood pressure between baseline and end study for intervention 
and control groups 
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Patient allocation and evaluation 
Assessed for eligibility (n=80) 
Excluded  (n=24) 
♦   Not meeting inclusion criteria (n=5) 
♦   Declined to participate (n=15) 
♦   Other reasons (n=4) 
Analysed  (n=25) 
♦ Excluded from analysis (n=1) 
Lost to follow-up (n=0) 
Discontinued intervention (n=1) 
Allocated to intervention (n=28) 
♦ Received allocated intervention (n=26) 
♦ Did not receive allocated intervention (n=2) 
Lost to follow-up (give reasons) (n=1) 
Discontinued intervention (give reasons) (n=0) 
Allocated to intervention (n=28) 
♦ Received allocated intervention (n=24) 
♦ Did not receive allocated intervention (n=4) 
Analysed  (n= 23) 
♦ Excluded from analysis (n=1) 
 
Allocation 
Analysis 
Follow-Up 
Randomized (n=56) 
Enrollment 
Table 1.  
 Control  
(n=23) 
Intervention 
(n=25) 
 
 Mean SD Mean SD 
 
Age (years) 
 
60.7 
 
12.0 
 
55.7 
 
15.1 
 
Male:female (numbers) 
 
14:9 
  
14:11 
 
 
Mean 24 hr systolic BP mmHg 
 
156.0 
 
10.7 
 
149.3 
 
15.2 
 
Mean 24 hr diastolic BP 
mmHg 
 
85 
 
5.8 
 
85 
 
6.3 
 
Diabetes (%) 
 
14 
 
(60) 
 
17 
 
68 
 
Glycosylated Hb (%) 
 
8.6 
 
1.8 
 
8.9 
 
1.9 
 
GFR ml/min/1.73m2 
 
42 
 
15.3 
 
41 
 
17.2 
 
Urinary sodium mmol/24hr 
 
Urinary Potassium mmol/24hr 
 
259 
 
39 
 
47.1 
 
6.9 
 
263 
 
43 
 
54.0 
 
4.0 
 
Urinary creatinine mmol/24hr 
 
11.15 
 
1.9 
 
10.75 
 
1.3 
 
Number BP 
medication/patient1 
 
3 
 
(2,4) 
 
3 
 
(2,4) 
 
Total body water (kg) 
 
33.1 
 
5.9 
 
33.4 
 
5.2 
 
BMI (kg/cm2) 
 
27.1 
 
5.2 
 
26.6 
 
5.4 
 
Physical activity (steps/day)1 
 
2,534 
 
1,101 
 
2,471 
 
1,419 
 
1Median with interquartile range                                                                                                                                                                                                 
 GFR - Glomerular filtration rate, BMI-body mass index. No statistical significant differences between 
the two groups       
 

